Absent a federal committee’s recommendation, Duchenne muscular dystrophy advocates are trying to get states to adopt ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ...

Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, ...

According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...

Health plans must embrace real-time member awareness, timely clinical context and actionable insights to realize the benefits ...

The financial balancing act between providers, government programs and commercial insurers, according to Christoph Dankert, ...

Employers are key to transforming healthcare by creating competitive, cost-effective networks independent of federal policy ...